3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
186
Lymphoid
124
Myeloid
57
Plasma cell
23
Classical hematology
23
Sarcoma
16
Dermatologic
11
Other neoplasm
3
Genitourinary
2
Other
1
Conditions
Mucositis
3
Osteosarcoma
1
Neurotoxicity Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Interventions
pegaspargase
1
nelarabine
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Vitamin D
1
Vincristine
1
Therapeutics
1
Rituximab
1
Radiotherapy
1
Psychology, Positive
1
Passive Cutaneous Anaphylaxis
1
Morphine
1
Methotrexate
1
Methods
1
Methadone
1
Mercaptopurine
1
Melphalan
1
Imatinib Mesylate
1
Hydromorphone
1
High-Energy Shock Waves
1
Gelclair
1
Furosemide
1
Fibroblast Growth Factor 7
1
Etoposide
1
Drug Therapy
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Calcium Citrate
1
Calcium Carbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Methotrexate
×
Other
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed